2Morooka T,Inoue T,Kotooka N,Fujimatsu D,et al.An appropriate indication for the initiation of beta-blocker therapy in dilated cardiomyopathy[J].Cardiology,2006,105(1):61-66.
21.Packer M,Bristow M R,Cohn I N,et al.Effect of carvedilol on morbidity and mortality in chronic heart failure.N Engl J Med,1996,334:1349-1355.
3CIBIS-Ⅱ investigators and committees.The cardiac insufficiency bisoprolol study Ⅱ(CIBIS Ⅱ) a randomized trial.Lancet,1999,353(9146): 9-13.
4MERIT-HF study group.Effect of metoprolo CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF).Lancet,1999,353: 2001-2007.
5Bristow M R.Mechanism of action of beta-blocking agents in heart failure.Am J Cardiol,1997,80(11A):26L-40L.
6Bristow M R.Why does the myocardium fail? Insights from basic science.Lancet,1998,352(Suppl 1):8-14.
7Pepper G S,Lee R W.Sympathetic activation in heart failure and its treatment with β-blockade.Arch Intern Med,1999,159(8):225-234.
8Squire I B,Barnett D B.The rational use of β-adrenoceptor blockers in the treatment of heart failure.The changing face of an old therapy.Br J Clin Pharmacol,2000,49:1-9.
9Eichhorn E J,Bristow M R.Medical therapy can improve the biological properties of the chronically failing heart.A new era in the treatment of heart failure.Circulation,1996,94(9):2285-2296.
10Constant J.A review of why and how we may use β-blockers in congestive heart failure.Chest,1998,113:800-808.
